(Q35009891)

English

A three-marker FISH panel detects more genetic aberrations of AR, PTEN and TMPRSS2/ERG in castration-resistant or metastatic prostate cancers than in primary prostate tumors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

A three-marker FISH panel detects more genetic aberrations of AR, PTEN and TMPRSS2/ERG in castration-resistant or metastatic prostate cancers than in primary prostate tumors (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

Brenda F. Kurland

object named as

Brenda F Kurland

4

0 references

Robert L Vessella

10

object named as

Robert Vessella

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Celestia Higano

8

object named as

Celestia S Higano

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

6

object named as

Ilsa Coleman

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

11

object named as

Peter S Nelson

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

author name string

Xiaoyu Qu

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Grace Randhawa

2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Cynthia Friedman

3

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Lena Glaskova

5

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Elahe Mostaghel

7

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Christopher Porter

9

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Min Fang

12

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

language of work or name

0 references

publication date

30 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

e74671

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

copyright license

Creative Commons Attribution 4.0 International

30 September 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

A novel four-color fluorescence in situ hybridization assay for the detection of TMPRSS2 and ERG rearrangements in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

The mutational landscape of lethal castration-resistant prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

Exome sequencing of prostate cancer supports the hypothesis of independent tumour origins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

ETS gene fusions in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

Genomic alterations indicate tumor origin and varied metastatic potential of disseminated cells from prostate cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

Androgen Receptor Gene Amplification and Protein Expression in Recurrent Prostate Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

Models for longitudinal data: a generalized estimating equation approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

8 July 2018

TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0074671

21 January 2018

PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0074671

21 January 2018

Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

26 October 2018

Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787014

26 October 2018

Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0074671

21 January 2018

Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24098661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic profile identification in clinically localized prostate carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24098661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ThePTEN gene in locally progressive prostate cancer is preferentially inactivated by bi-allelic gene deletion

1 reference

https://pubmed.ncbi.nlm.nih.gov/24098661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytogenetic profiles as additional markers to pathological features in clinically localized prostate carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24098661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0074671

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

2013PLoSO...874671Q

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35009891&oldid=2191536597"